Why do some here think the AGILE study will be negative. Could any such views be supported by the data already known? Other than missing the goal for the next stage what has changed in the OS, PFS being already shown to be better than TMZ for the scope of patients being on our trials.
- Forums
- ASX - By Stock
- KZA
- Excellent interim DIPG data from PNOC
Excellent interim DIPG data from PNOC, page-6
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online